C. Michael Stein

1.7k total citations · 2 hit papers
9 papers, 1.1k citations indexed

About

C. Michael Stein is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, C. Michael Stein has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in C. Michael Stein's work include Pharmacogenetics and Drug Metabolism (4 papers), Systemic Lupus Erythematosus Research (2 papers) and Hormonal Regulation and Hypertension (1 paper). C. Michael Stein is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Systemic Lupus Erythematosus Research (2 papers) and Hormonal Regulation and Hypertension (1 paper). C. Michael Stein collaborates with scholars based in United States, Denmark and Zimbabwe. C. Michael Stein's co-authors include Teri E. Klein, Mary V. Relling, Kjeld Schmiegelow, Sook Wah Yee, C-H Pui, William J. Sandborn, William E. Evans, Michelle Whirl‐Carrillo, Stephen E. Kimmel and Brian F. Gage and has published in prestigious journals such as Blood, Clinical Pharmacology & Therapeutics and Arthritis Research & Therapy.

In The Last Decade

C. Michael Stein

9 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

2011 473 citations J. A. Johnson, Li Gong et al. Clinical Pharmacology & Therapeutics profile →
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

2011 401 citations Mary V. Relling, William J. Sandborn et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Michael Stein United States	7	574	267	192	176	175	9	1.1k
Samuel G. Johnson United States	18	532 0.9×	281 1.1×	137 0.7×	192 1.1×	139 0.8×	36	1.3k
Michael Pacanowski United States	21	319 0.6×	177 0.7×	59 0.3×	81 0.5×	249 1.4×	66	1.3k
HL McLeod United States	8	563 1.0×	155 0.6×	164 0.9×	87 0.5×	153 0.9×	15	927
Sony Tuteja United States	20	283 0.5×	198 0.7×	110 0.6×	109 0.6×	276 1.6×	71	1.3k
MV Relling United States	11	697 1.2×	465 1.7×	348 1.8×	259 1.5×	352 2.0×	13	1.3k
Roseann S. Gammal United States	14	976 1.7×	525 2.0×	137 0.7×	229 1.3×	183 1.0×	28	1.4k
Céline Narjoz France	16	250 0.4×	111 0.4×	156 0.8×	121 0.7×	311 1.8×	42	1.1k
Mark A. Milad United States	15	189 0.3×	115 0.4×	57 0.3×	58 0.3×	126 0.7×	24	966
Julia M. Barbarino United States	13	567 1.0×	356 1.3×	75 0.4×	157 0.9×	418 2.4×	14	1.6k
Marja K. Pasanen Finland	13	754 1.3×	577 2.2×	89 0.5×	88 0.5×	273 1.6×	16	2.1k

Countries citing papers authored by C. Michael Stein

Since Specialization

Citations

This map shows the geographic impact of C. Michael Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Michael Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Michael Stein more than expected).

Fields of papers citing papers by C. Michael Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Michael Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Michael Stein. The network helps show where C. Michael Stein may publish in the future.

Co-authorship network of co-authors of C. Michael Stein

This figure shows the co-authorship network connecting the top 25 collaborators of C. Michael Stein. A scholar is included among the top collaborators of C. Michael Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Michael Stein. C. Michael Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Bathon, Joan M., Michael Centola, Xiaoqian Liu, et al.. (2023). Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis. Arthritis Research & Therapy. 25(1). 213–213. 2 indexed citations

Byram, Kevin, Annette Oeser, MacRae F. Linton, et al.. (2018). Exercise is Associated With Increased Small HDL Particle Concentration and Decreased Vascular Stiffness in Rheumatoid Arthritis. JCR Journal of Clinical Rheumatology. 24(8). 417–421. 12 indexed citations

Stein, C. Michael, et al.. (2013). Warfarin pharmacogenomics in children. Pediatric Blood & Cancer. 60(9). 1402–1407. 9 indexed citations

Johnson, J. A., Li Gong, Michelle Whirl‐Carrillo, et al.. (2011). Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing. Clinical Pharmacology & Therapeutics. 90(4). 625–629. 473 indexed citations breakdown →

Relling, Mary V., William J. Sandborn, Kjeld Schmiegelow, et al.. (2011). Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing. Clinical Pharmacology & Therapeutics. 89(3). 387–391. 401 indexed citations breakdown →

Gong, Inna Y., Rommel G. Tirona, Ute I. Schwarz, et al.. (2011). Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Blood. 118(11). 3163–3171. 64 indexed citations

Oeser, Annette, Cecilia P. Chung, Yu Asanuma, Ingrid Avalos, & C. Michael Stein. (2005). Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis & Rheumatism. 52(11). 3651–3659. 114 indexed citations

Xie, Hong‐Guang, C. Michael Stein, Richard B. Kim, et al.. (1999). Allelic, genotypic and phenotypic distributions of S-mephenytoin 4???-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world. Pharmacogenetics and Genomics. 9(5). 539–550. 6 indexed citations

Stein, C. Michael, et al.. (1992). Antihypertensive effects of low doses of hydrochlorothiazide in hypertensive black Zimbabweans. International Journal of Cardiology. 37(2). 231–235. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact